Rating : 10/10 (⭐⭐⭐⭐⭐)
🔹Prof. Dr. Uwe Wagner is the Medical Managing Director of the University Hospital Marburg. With the five-member management team of the UKGM is once again complete.
🔹Prof. Wagner is serving as the Director of the Marburg Clinic for Gynecology and Obstetrics in addition to his role as the Medical Managing Director.
🔹Prof. Dr. med. Ingo Bernard Runnebaum's multifaceted career, his dedication to research, and his contributions to the medical field. It paints a comprehensive picture of a professional who has traversed various domains, leaving a lasting impact on medicine.
🔹1982 to 1988: Prof. Wagner's illustrious career in the field of gynecology and obstetrics began with his six-year journey in Human Medicine at the Rheinische-Friedrich-Wilhelms-Universität in Bonn.
🔹1995: He took on the role of a research assistant at the Bonner Universitäts-Frauenklinik under the leadership of Prof. Dr. D. Krebs.
🔹1997: He achieved specialization as a specialist in gynecology and obstetrics, marking a significant milestone in his career. Following this, he assumed the position of Senior Physician at the University Women's Clinic in Bonn.
🔹1998: Prof. Wagner transitioned to Tübingen and served as the Deputy Medical Director of the university's Women's Clinic until 2002.
🔹2002: He embarked on a new chapter as he assumed the role of Director of the Klinik für Gynäkologie, Gyn. Endokrinologie und Onkologie in Marburg.
🔹2014: he took charge of the Klinik für Frauenheilkunde und Geburtshilfe on the Lahnbergen after a restructuring, continuing his role as its Director.
🔹Since 2002: Prof. Wagner's influence extends beyond clinical practice as he has been a member of the Fachausschuss Gynäkologie (Specialist Committee for Gynecology) at the Geschäftsstelle Qualitätssicherung Hessen (Quality Assurance Office Hessen)
🔹2012: He is also a recurring member of the Bundesfachgruppe operative Gynäkologie (Federal Specialist Group for Operative Gynecology).
🔹He has been coordinating the S3 guideline "Maligne Ovarialtumoren" (Malignant Ovarian Tumors) and has been actively involved in developing quality indicators based on this guideline. Additionally, he serves as the spokesperson for the German Board of Gynecology and Obstetrics.
🔹Prof. Wagner's research endeavors predominantly focus on women's cancer, and he has been a prolific contributor to the field through extensive publications.
🔹Specialist for Gynecology
